Second-line treatment with venetoclax costs less than second-line BTK inhibitor treatment for chronic lymphocytic leukemia, data suggest.

Nearly two-thirds of patients with advanced urothelial cancer treated at oncology clinics across the US did not proceed to second-line therapy after first-line treatment.

Lymph node-positive (pN1) prostate cancer is a heterogeneous disease with varying mortality risks, investigators reported at the American Urological Association 2024 annual meeting (AUA 2024) in San ...

Patients with concomitant congestive heart failure or sleep apnea were more likely to experience voiding dysfunction after NMIBC treatment.

The FDA is reviewing the biologics license application for a new subcutaneous formulation of Opdivo (nivolumab).

The FDA is expected to make decisions about therapies for small-cell lung cancer and myelodysplastic syndrome next month. The US Food and Drug Administration (FDA) is expected to decide in June ...

A new study suggests that starting a patient on preferred targeted therapy within 1 year of metastatic non-small cell lung cancer diagnosis can still improve overall survival, when compared to other ...

The results of this study support the call for coordinated efforts to address systemic racism driving health inequities, according to researchers. Black adolescent and young adult (AYA) cancer ...

This story was originally published by ProPublica. In late 2020, Dr Debby Day said her bosses at Cigna gave her a stark warning. Work faster, or the company might fire her.

Change Healthcare expects full operations to resume next year, according to its chief financial officer. Two months after a ...

Cigna tracks every minute that its staff doctors spend deciding whether to pay for health care.

For years, the Department of Veterans Affairs has provided disability compensation for cancers and other diseases connected to Agent Orange exposure, but vets who were exposed to the herbicide on a US ...